Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 25;8(4):468.
doi: 10.3390/microorganisms8040468.

Steroid Derivatives as Potential Antimicrobial Agents Against Staphylococcus aureus Planktonic Cells

Affiliations

Steroid Derivatives as Potential Antimicrobial Agents Against Staphylococcus aureus Planktonic Cells

Adriana Vollaro et al. Microorganisms. .

Abstract

In this work, the antibacterial activity of deflazacort and several of its synthetic precursors was tested against a panel of bacterial pathogens responsible for most drug-resistant infections including Staphylococcus aureus, Enterococcus spp., Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. The derivative of deflazacort, PYED-1 (pregnadiene-11-hydroxy-16α,17α-epoxy-3,20-dione-1) showed the best antibacterial activity in a dose-dependent way. We focused on the action of PYED-1 against S. aureus cells. PYED-1 exhibited an additive antimicrobial effect with gentamicin and oxacillin against the methicillin-resistant S. aureus isolate 00717. In addition to its antimicrobial effect, PYED-1 was found to repress the expression of several virulence factors of S. aureus, including toxins encoded by the hla (alpha-haemolysin), hlb (beta-haemolysin), lukE-D (leucotoxins E-D), and sea (staphylococcal enterotoxin A) genes, and cell surface factors (fnbB (fibronectin-binding protein B) and capC (capsule biosynthesis protein C)). The expression levels of autolysin isaA (immunodominant staphylococcal antigen) were also increased.

Keywords: Staphylococcus aureus; anti-virulence agent; antimicrobial activity; checkerboard assay; deflazacort (DFZ); multidrug pathogens; quantitative real-time PCR; steroids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Deflazacort and its synthetic precursor PYED-1 (pregnadiene-11-hydroxy-16α,17α-epoxy-3,20-dione-1).
Figure 2
Figure 2
Synthetic transformations from brominated compound 9 to epoxide PYED-1.
Figure 3
Figure 3
Deflazacort (DFZ) glucocorticoid precursors and analogues.
Figure 4
Figure 4
Killing kinetics for S. aureus following treatment with the PYED-1. Growth kinetics were monitored following exposure to PYED-1 at 1 x MIC, 2 x MIC, and 4 x MIC.

References

    1. Boev C., Kiss E. Hospital-Acquired Infections. Crit. Care Nurs. Clin. North Am. 2017;29:51–65. doi: 10.1016/j.cnc.2016.09.012. - DOI - PubMed
    1. Tommasi R., Brown D.G., Walkup G.K., Manchester J.I., Miller A.A. ESKAPEing the labyrinth of antibacterial discovery. Nat. Rev. Drug Discov. 2015;14:529–542. doi: 10.1038/nrd4572. - DOI - PubMed
    1. Schroeder M., Brooks B.D., Brooks A.E. The Complex Relationship between Virulence and Antibiotic Resistance. Genes. 2017;8:39. doi: 10.3390/genes8010039. - DOI - PMC - PubMed
    1. Ke S. Recent Progress of Novel Steroid Derivatives and Their Potential Biological Properties. Mini-Rev. Med. Chem. 2018;18:745–775. doi: 10.2174/1389557517666171003103245. - DOI - PubMed
    1. Shieh P.B., McIntosh J., Jin F., Souza M., Elfring G., Narayanan S., Trifillis P., Peltz S.W., McDonald C., Darras B., et al. Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial. Muscle Nerve. 2018;58:639–645. doi: 10.1002/mus.26191. - DOI - PMC - PubMed

LinkOut - more resources